GlassScriptPhysician profile
Ansel T Johnson
NPI 1023106309
$15,461.21
in general payments reported to CMS, 2019-2025
28 companies · $3,297 in 2025
The $3,297 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,207 · 2020: $434 · 2021: $1,835 · 2022: $805 · 2023: $4,733 · 2024: $3,150 · 2025: $3,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,612 · Honoraria: $3,145 · Consulting Fee: $2,180 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,100 · Entertainment: $126 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,611.98 |
| Honoraria | $3,144.63 |
| Consulting Fee | $2,180.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,100.00 |
| Entertainment | $126.26 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $3,850.45 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $3,178.96 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $1,247.70 | 2019-2025 | Precision 1, Total30, Precision7 |
| Glaxosmithkline, LLC. | $1,095.00 | 2021 | |
| Abbvie INC. | $846.23 | 2022-2025 | |
| Sight Sciences, INC. | $778.08 | 2019-2024 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $669.66 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $649.32 | 2020-2025 | Acuvue |
| Allergan, INC. | $630.24 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $541.02 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Biotissue Holdings INC. | $315.97 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $289.76 | 2019-2024 | |
| Visioneering Technologies, INC. | $280.00 | 2019 | |
| Rxsight INC | $232.69 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Dompe US, INC. | $232.48 | 2021-2025 | Oxervate |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $126.26 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $122.33 | 2023-2025 | Clariti Contact Lens, Paragon Crt |
| Dexcom, INC. | $91.06 | 2023 | Dexcom G7 Gss (161) |
| Maculogix, INC. | $72.90 | 2019 | |
| Shire North American Group INC | $55.31 | 2019 | |
| Topcon Healthcare, INC. | $50.79 | 2023 | |
| Aerie Pharmaceuticals, INC. | $23.20 | 2019 | |
| Vyera Pharmaceuticals, LLC | $23.08 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.60 | 2019 | |
| Tearlab Corp | $17.60 | 2021 | |
| Abb Con-Cise Optical Group LLC | $15.86 | 2019 | |
| Quidel Corporation | $7.66 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ansel Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.